Endocyte Announces First Quarter 2015 Earnings Conference Call

WEST LAFAYETTE, Ind., April 30, 2015 (GLOBE NEWSWIRE) -- Endocyte, Inc., (Nasdaq: ECYT) announced today that the company will host a conference call on Thursday, May 7, at 4:30 p.m. EDT to discuss its first quarter financial results and provide an operational update.

Investors and the general public are invited to listen to a live webcast of the call, which can be accessed in the Investors & News section of the Company's website at www.endocyte.com or by dialing (877) 845-0711 (U.S./Canada) or (760) 298-5081 (International).

The webcast will be recorded and available on the Company's website for one week following the call.

About Endocyte

Endocyte is a biopharmaceutical company and leader in developing targeted small molecule drug conjugates (SMDCs) and companion imaging agents for personalized therapy in cancer and other serious diseases. Endocyte uses its proprietary technology to create novel SMDCs and companion imaging agents for personalized targeted therapies. The company's SMDCs actively target receptors that are expressed or over-expressed on diseased cells, relative to healthy cells. This targeted approach is designed to enable the treatment of patients with highly potent drugs into these cells. The companion imaging agents are designed to identify patients whose disease expresses the molecular target of the therapy and who therefore may be more likely to benefit from treatment. For more information, visit http://www.endocyte.com.

CONTACT: Stephanie Ascher, Stern Investor Relations, Inc.,
         (212) 362-1200, [email protected]

You May Also Be Interested In

• Are we witnessing a fundamental or speculative rally in the S&P 500?
• Bernstein cuts food giants as GLP-1s, health trends threaten growth outlooks
• Veeva Systems beats estimates on AI progress